DelveInsight, a leading provider of healthcare competitive intelligence, partnered with a large pharmaceutical company seeking to advance their API and FD development and assessed various CDMO ...
Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have been given an average rating of “Hold” by the seven analysts that are presently covering the company, Marketbeat.com reports. Seven analysts ...
StockNews.com began coverage on shares of Catalent (NYSE:CTLT – Free Report) in a research report sent to investors on Friday ...
Pfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated ...
S&P MidCap 400 constituent Lennox International Inc. (NYSE: LII) will replace Catalent Inc. (NYSE: CTLT) in the S&P 500, ...
Novo Holdings has completed the previously announced acquisition of Catalent in a $16.5bn all-cash transaction. The European Commission (EC) gave its approval in early December 2024. Catalent's ...
Novo Nordisk has purchased three of Catalent’s fill-finish facilities from Novo Holdings. Credit: © 2024 Novo Nordisk A/S. Novo Holdings has completed the ...
(RTTNews) - Wednesday, Novo Holdings A/S completed the acquisition of Catalent, Inc. (CTLT), a global contract development and manufacturing organization, in an all-cash transaction worth ...
Novo Holdings said that it completed it's $16.5 billion acquisition of Catalent Inc. (NYSE:CTLT). Shortly following the ...
The latest announcement is out from Catalent ( (CTLT) ).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback